✦ LIBER ✦

Efficacy of pregabalin in a case of stiff-person syndrome: Clinical and neurophysiological evidence

✍ Scribed by G. Squintani; T. Bovi; L. Ferigo; A.M. Musso; S. Ottaviani; G. Moretto; F. Morgante; M. Tinazzi

Book ID: 119304338
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 251 KB
Volume: 314
Category: Article
ISSN: 0022-510X
DOI: 10.1016/j.jns.2011.10.023

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical hallmarks and epidemiology of s

Clinical hallmarks and epidemiology of stiff person syndrome in Tanzania

✍ Dekker, M.; Urasa, S.; Maro, V.; Kinabo, G.; Howlett, W. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 64 KB

PET evidence of central GABAergic change

PET evidence of central GABAergic changes in stiff-person syndrome

✍ Daniela Perani; Valentina Garibotto; Andrea Panzacchi; Rosa Maria Moresco; Paola 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

## Abstract We measured expression of central nervous system GABA‐A receptors with ^11^C‐flumazenil (^11^C‐FMZ) and PET in two subjects with stiff person syndrome (SPS). We found reduced ^11^C‐FMZ binding potential (BP) in motor‐premotor cortex, and increased ^11^C‐FMZ BP in the cerebellar nuclei.

Poster 245: Utilization of Dantrolene in

Poster 245: Utilization of Dantrolene in Stiff-Person Syndrome: A Case Report

✍ John M. Vasudevan; Nethra Ankam; Sherin K. Fetouh; Adam L. Schreiber 📂 Article 📅 2009 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 46 KB

Pathological findings in a case of stiff

Pathological findings in a case of stiff person syndrome with anti-GAD antibodies

✍ Jonathan Witherick; J. Robin Highley; Marios Hadjivassiliou 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 1023 KB

Posterior cortical atrophy (PCA) represents a degenerative disorder characterized by the development of higherorder visual deficit. 1 PCA may result from heterogeneous pathologies that make up tauopathies. An increasing number of mutations in the tau gene (microtubule-associated protein tau [MAPT])

A case of stiff-person syndrome, type 1

A case of stiff-person syndrome, type 1 diabetes, celiac disease and dermatitis herpetiformis

✍ Eoin P. O'Sullivan; Lucy-Ann Behan; Tom F.J. King; Orla Hardiman; Diarmuid Smith 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 109 KB

A therapeutic trial of milacemide in myo

A therapeutic trial of milacemide in myoclonus and the stiff-person syndrome

✍ P. Brown; P. D. Thompson; J. C. Rothwell; B. L. Day; Prof. C. D. Marsden 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 269 KB 👁 1 views

We investigated the therapeutic effects of milacemide in seven patients with myoclonus and three patients with the stiff-person syndrome in an open-label trial. Milacemide was initiated at 800 mg/day and was gradually increased to a maximum dosage of 2,400 mg/day. No significant improvement occurred